Kaplan PKD Roundtable: Exploring Novel PKD Therapeutics

15 Apr 2024 03:00 pm 04:00 pm
Hall C4
MattBecka Chairperson Polycystic Kidney Disease FoundationUnited States

Session description:
The session will provide a discussion of novel therapeutic opportunities that are emerging from research on Autosomal Dominant Polycystic Kidney Disease and will include presentation of the Lillian Jean Kaplan Prize
Learning objectives:
Discuss new directions for gene therapy for ADPKD. Explore therapeutic options that are designed to target metabolic abnormalities. Review strategies for increasing the functional expression of mutant forms of polycystic kidney disease proteins. Discuss design and recruitment for clinical trials of novel therapies for ADPKD.

Time Session
03:00 pm
03:05 pm
Welcome and Highlights of PKD Foundation
MattBecka Speaker mattb@pkdcure.orgPolycystic Kidney Disease FoundationUnited States
03:05 pm
03:10 pm
Introduction of the Lillian Jean Kaplan Prize
VicenteTorres Speaker torres.vicente@mayo.eduMayo ClinicUnited States
03:10 pm
03:30 pm
Identifying Novel Therapeutic Targets for Polycystic Kidney Disease
MichaelCaplan Speaker michael.caplan@yale.eduYale University School orf MedicineUnited States
03:30 pm
03:55 pm
Roundtable Discussion
MichaelCaplan Speaker michael.caplan@yale.eduYale University School orf MedicineUnited States
Roundtable Discussion
VicenteTorres Speaker torres.vicente@mayo.eduMayo ClinicUnited States
Roundtable Discussion
AlessandraBoletta Speaker boletta.alessandra@hsr.itSan Raffaele Scientific InstituteItaly
Roundtable Discussion
PeterHarris Speaker harris.peter@mayo.eduMayo ClinicUnited States
Roundtable Discussion
AlfredoWassermann Speaker awasser@gmail.comFEPREVAArgentina